Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's

Completed · Phase 3

Conditions studied: Alzheimer Disease, Dementia

In brief

The purpose of the study is to evaluate the change in cognitive ability and activities of daily living in patients with Alzheimer's disease (AD) as measured by specific evaluations during 18 months of dosing.

Key facts

Study ID

NCT00105547

Run by

Myrexis Inc.

People needed

1600

Starts

2005-02-01

Expected to finish

2008-05-01

Last updated by the study team

2009-05-05

Who can join

Age: 55 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Have had a diagnosis of probable Alzheimer's disease.
• Men or women ages 55 years or greater and living in the community at the time of enrollment (i.e., not living in a rest home or nursing care facility).
• Signed the subject Informed Consent Form and is willing and able to participate for the duration of the study.
• Ability to read and understand English or Spanish to ensure compliance with cognitive testing and study visit procedures.
• Female subjects must be surgically sterile or postmenopausal for > 1 year.
• Subjects currently taking approved medication for Alzheimer's disease for at least six months prior to day 1 may be enrolled.
• Subjects must have a reliable caregiver who can read, understand and speak English or Spanish.

You may not qualify if…

• Current evidence of other causes of dementia.
• History or evidence of, active malignancy, except for basal cell carcinoma or squamous cell carcinoma of the skin, within the 24 months prior to entry. Men with prostate cancer may be enrolled at the discretion of the sponsor.
• Chronic or acute renal, hepatic or metabolic disorder.
• Use of any investigational therapy within 30 days, or 5 half-lives, whichever is longer, and/or use of AD immunotherapy prior to screening.
• Major surgery and related complications not resolved within 12 weeks prior to Day 1.

Where it is running

• Study site — Huntsville, Alabama, United States
• Study site — Mesa, Arizona, United States
• Study site — Peoria, Arizona, United States
• Study site — Phoenix, Arizona, United States
• Study site — Sun City, Arizona, United States
• Study site — Tucson, Arizona, United States
• Study site — Little Rock, Arkansas, United States
• Study site — Fresno, California, United States
• Study site — Irvine, California, United States
• Study site — La Jolla, California, United States
• Study site — Lafayette, California, United States
• Study site — Laguna Hills, California, United States
• Study site — Long Beach, California, United States
• Study site — Los Angeles, California, United States
• Study site — Newport Beach, California, United States
• Study site — Newport Beach, California, United States
• Study site — Oceanside, California, United States
• Study site — Rancho Mirage, California, United States
• Study site — Sacramento, California, United States
• Study site — San Diego, California, United States
• Study site — San Francisco, California, United States
• Study site — San Francisco, California, United States
• Study site — Vista, California, United States
• Study site — Denver, Colorado, United States
• Study site — Alabaster, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.